Saturday, 20 July 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 20 July 2024
Listen to this story 
News

CSL scores world-first approval

Posted 30 November 2023 AM

CSL has landed its first regulatory approval for its new self-amplifying messenger RNA technology.

This week Japan's Ministry of Health, Labor and Welfare granted approval for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, for initial vaccination and booster for adults 18 years and older.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (15)

Clinical & Medical, R&D (15)

Regulatory, Pharmacovigilance & QA (9)

Other (28)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.